Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review
- PMID: 28567431
- PMCID: PMC5445722
- DOI: 10.1093/ofid/ofx066
Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review
Abstract
Background: Rotavirus vaccine schedules may impact vaccine response among children in low- and middle-income countries (LMICs). Our objective was to review the literature evaluating the effects of monovalent (RV1) or pentavalent rotavirus vaccines schedules on vaccine response.
Methods: We searched PubMed, Web of Science, Embase, and ClinicalTrials.gov for eligible trials conducted in LMICs comparing ≥2 vaccine schedules and reporting immunologic response or efficacy. We calculated seroconversion proportion differences and geometric mean concentration (GMC) ratios with 95% confidence intervals.
Results: We abstracted data from 8 eligible trials of RV1. The point estimates for seroconversion proportions difference ranged from -0.25 to -0.09 for the 6/10-week schedule compared with 10/14. The range for the 6/10/14- compared with 10/14-week schedule was -0.02 to 0.10. Patterns were similar for GMC ratios and efficacy estimates.
Conclusions: The commonly used 6/10-week RV1 schedule in LMICs may not be optimal. Further research on the effect of rotavirus schedules using clinical endpoints is essential.
Keywords: infant; rotavirus; vaccine; vaccine schedule; viral gastroenteritis.
© The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures
References
-
- Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:220–36. - PubMed
-
- Path. Rotavirus vaccines overview Available at: http://sites.path.org/rotavirusvaccine/country-introduction-maps-and-spr... Accessed 24 August 2016.
-
- GlaxoSmithKline. Highlights of Prescribing Information: Rotarix (Rotavirus Vaccine, Live, Oral. Available at: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Presc.... Accessed 9 May 2017.
-
- Merck & Co. Inc. Highlights of Prescribing Information: RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent. Available at: https://www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf. Accessed 9 May 2017.
-
- Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289–98. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
